Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX1 SOX2 ZNF142 ZNF613 ZNF473 ZBTB48 ZNF705EP TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 APP ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G PASD1 ZNF419 ZNF257 ZNF655 PBX1 PBX2 TBX20 ZNF99 LEF1	4.43e-08	1459	137	30	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SOX1 SOX2 ZNF142 ZNF473 ZBTB48 ZNF705EP TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G PASD1 ZNF419 ZNF257 ZNF655 PBX1 PBX2 TBX20 ZNF99 LEF1	2.88e-07	1412	137	28	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX1 SOX2 ZNF613 ZNF473 ZBTB48 ZNF521 ZNF208 ZNF621 ZNF772 ZNF519 APP ZNF236 CREB5 ZBTB14 ZFX ZNF260 PASD1 ZNF419 ZNF257 ZNF655 PBX1 PBX2 TBX20 ZNF99 LEF1	1.10e-06	1244	137	25	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX1 SOX2 ZNF613 ZNF473 ZBTB48 ZNF521 ZNF208 ZNF621 ZNF772 ZNF519 APP ZNF236 CREB5 ZBTB14 ZFX ZNF260 PASD1 ZNF419 ZNF257 ZNF655 PBX1 PBX2 TBX20 ZNF99 LEF1	1.62e-06	1271	137	25	GO:0000987
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.89e-06	35	137	5	GO:0015020
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.82e-05	28	137	4	GO:0001972
GeneOntologyMolecularFunction	kinase activity	TNIK PDK4 NTRK2 RPS6KA2 SOSTDC1 CDK11A TRRAP CKM SEPHS1 TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	7.14e-05	764	137	16	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	TNIK PDK4 NTRK2 RPS6KA2 PARP8 SOSTDC1 CDK11A TRRAP CKM SEPHS1 TAOK3 PAPOLA CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	7.57e-05	938	137	18	GO:0016772
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	SOX1 SOX2 ZNF473 ZNF521 ZNF208 ZNF519 CREB5 ZFX PBX1 PBX2 TBX20 ZNF99 LEF1	1.29e-04	560	137	13	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	SOX1 SOX2 ZNF473 ZNF521 ZNF208 ZNF519 CREB5 ZFX PBX1 PBX2 TBX20 ZNF99 LEF1	1.44e-04	566	137	13	GO:0001216
GeneOntologyMolecularFunction	protein kinase activity	TNIK PDK4 NTRK2 RPS6KA2 SOSTDC1 CDK11A TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	2.54e-04	600	137	13	GO:0004672
GeneOntologyMolecularFunction	retinoid binding	UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.26e-04	48	137	4	GO:0005501
GeneOntologyMolecularFunction	isoprenoid binding	UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.54e-04	49	137	4	GO:0019840
GeneOntologyMolecularFunction	protein serine kinase activity	TNIK RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 CDK11B MAP2K2 CSNK2A3	9.14e-04	363	137	9	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	TNIK RPS6KA2 SOSTDC1 CDK11A TAOK3 CSNK2A1 CSNK2A2 CDK11B MAP2K2 CSNK2A3	1.03e-03	446	137	10	GO:0004674
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	TNIK PDK4 NTRK2 RPS6KA2 SOSTDC1 CDK11A TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	1.20e-03	709	137	13	GO:0016773
GeneOntologyBiologicalProcess	vesicle cargo loading	CTAGE9 CTAGE6 SEC31A SEC31B CTAGE8 CTAGE15 CTAGE4	4.25e-09	36	141	7	GO:0035459
GeneOntologyBiologicalProcess	cell cycle process	SOX2 KNTC1 UBR2 KIF18A RPS6KA2 SPTBN1 CASP2 CDK11A APP TRRAP DSN1 TUBGCP6 PARD6B TAOK3 BRCA2 ARHGEF10 SLF2 CCNE2 CSNK2A1 ZNF655 CSNK2A2 FGFR2 CDK11B PBX1 TBX20 LEF1	4.59e-06	1441	141	26	GO:0022402
GeneOntologyBiologicalProcess	regulation of cell cycle process	SOX2 KNTC1 RPS6KA2 CASP2 CDK11A APP TRRAP TAOK3 BRCA2 SLF2 CCNE2 CSNK2A1 ZNF655 CSNK2A2 FGFR2 CDK11B PBX1 TBX20 LEF1	5.04e-06	845	141	19	GO:0010564
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.14e-05	21	141	4	GO:0052695
GeneOntologyBiologicalProcess	endoplasmic reticulum to Golgi vesicle-mediated transport	CTAGE9 CTAGE6 SEC31A SEC31B CTAGE8 CTAGE15 CTAGE4 MPPE1	1.39e-05	159	141	8	GO:0006888
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.78e-05	26	141	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.78e-05	26	141	4	GO:0006063
GeneOntologyBiologicalProcess	regulation of cell cycle	SOX2 KNTC1 RPS6KA2 CASP2 CDK11A APP TRRAP TAOK3 BRCA2 PTPRK SLF2 CCNE2 CSNK2A1 ZNF655 CSNK2A2 BOP1 FGFR2 CDK11B PBX1 TBX20 CSNK2A3 LEF1	4.32e-05	1256	141	22	GO:0051726
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT1A3 UGT2B4 UGT2B17	6.58e-05	12	141	3	GO:0052697
GeneOntologyBiologicalProcess	Golgi vesicle transport	CTAGE9 SPTBN1 CTAGE6 SEC31A SEC31B NBAS CTAGE8 CTAGE15 CTAGE4 MPPE1	1.16e-04	339	141	10	GO:0048193
GeneOntologyBiologicalProcess	regulation of protein localization to cell periphery	TNIK SPTBN1 AGR2 MAGI2 NRXN1 CSNK2A1 EPB41	1.77e-04	171	141	7	GO:1904375
GeneOntologyCellularComponent	endoplasmic reticulum exit site	CTAGE9 CTAGE6 SEC31A SEC31B CTAGE8 CTAGE15 CTAGE4 MPPE1	3.04e-10	42	139	8	GO:0070971
GeneOntologyCellularComponent	protein kinase CK2 complex	CSNK2A1 CSNK2A2 CSNK2A3	1.15e-06	4	139	3	GO:0005956
GeneOntologyCellularComponent	transferase complex, transferring phosphorus-containing groups	UGT3A1 CDK11A TRRAP PARD6B ATXN7 CCNE2 CSNK2A1 CSNK2A2 CDK11B CSNK2A3	8.38e-05	335	139	10	GO:0061695
GeneOntologyCellularComponent	serine/threonine protein kinase complex	CDK11A PARD6B CCNE2 CSNK2A1 CSNK2A2 CDK11B CSNK2A3	8.78e-05	157	139	7	GO:1902554
GeneOntologyCellularComponent	ESCRT-0 complex	STAM2 STAM	1.31e-04	3	139	2	GO:0033565
GeneOntologyCellularComponent	protein kinase complex	CDK11A PARD6B CCNE2 CSNK2A1 CSNK2A2 CDK11B CSNK2A3	1.44e-04	170	139	7	GO:1902911
GeneOntologyCellularComponent	excitatory synapse	NTRK2 PCLO NRXN1 FGFR2 CADPS2	7.47e-04	107	139	5	GO:0060076
Domain	Znf_C2H2-like	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF592 ATXN7 ZNF257 ZNF655 ZNF99	9.42e-09	796	133	23	IPR015880
Domain	Znf_C2H2	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF592 ATXN7 ZNF257 ZNF655 ZNF99	1.16e-08	805	133	23	IPR007087
Domain	ZnF_C2H2	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF592 ATXN7 ZNF257 ZNF655 ZNF99	1.24e-08	808	133	23	SM00355
Domain	ZINC_FINGER_C2H2_2	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF592 ZNF257 ZNF655 ZNF99	2.83e-08	775	133	22	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF592 ZNF257 ZNF655 ZNF99	2.96e-08	777	133	22	PS00028
Domain	-	ZNF142 ZNF613 ZNF473 ZBTB48 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF257 ZNF655 ZNF99	7.16e-08	679	133	20	3.30.160.60
Domain	zf-C2H2	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 ZBTB14 ZFX ZNF260 ZNF419 ZNF592 ZNF257 ZNF655 ZNF99	9.97e-08	693	133	20	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF142 ZNF613 ZNF473 ZBTB48 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 CREB5 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF257 ZNF655 ZNF99	1.02e-07	694	133	20	IPR013087
Domain	UDPGT	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.15e-07	21	133	5	PF00201
Domain	UDPGT	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.15e-07	21	133	5	PS00375
Domain	UDP_glucos_trans	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.15e-07	21	133	5	IPR002213
Domain	KRAB	ZNF613 ZNF473 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF705G ZNF419 ZNF257 ZNF99	5.16e-05	358	133	11	PS50805
Domain	KRAB	ZNF613 ZNF473 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF705G ZNF419 ZNF257 ZNF99	5.16e-05	358	133	11	PF01352
Domain	KRAB	ZNF613 ZNF473 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF705G ZNF419 ZNF257 ZNF99	6.77e-05	369	133	11	SM00349
Domain	KRAB	ZNF613 ZNF473 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF705G ZNF419 ZNF257 ZNF99	6.94e-05	370	133	11	IPR001909
Domain	zf-C2H2_6	ZNF613 ZNF473 ZBTB48 ZNF521 ZNF208 ZNF621 ZNF236 ZNF260 ZNF419 ZNF99	8.51e-05	314	133	10	PF13912
Domain	4_1_CTD	EPB41L3 EPB41	2.99e-04	4	133	2	PF05902
Domain	SAB	EPB41L3 EPB41	2.99e-04	4	133	2	PF04382
Domain	Band_4.1_C	EPB41L3 EPB41	2.99e-04	4	133	2	IPR008379
Domain	SAB_dom	EPB41L3 EPB41	2.99e-04	4	133	2	IPR007477
Domain	PBC	PBX1 PBX2	2.99e-04	4	133	2	PF03792
Domain	PBX	PBX1 PBX2	2.99e-04	4	133	2	IPR005542
Domain	PROTEIN_KINASE_ATP	TNIK NTRK2 RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	4.49e-04	459	133	11	PS00107
Domain	SOXp	SOX1 SOX2	4.96e-04	5	133	2	PF12336
Domain	SOX_fam	SOX1 SOX2	4.96e-04	5	133	2	IPR022097
Domain	Kinase-like_dom	TNIK NTRK2 RPS6KA2 CDK11A TRRAP TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	5.01e-04	542	133	12	IPR011009
Domain	FAT	TRRAP TMTC1	7.41e-04	6	133	2	PF02259
Domain	PIK-rel_kinase_FAT	TRRAP TMTC1	7.41e-04	6	133	2	IPR003151
Domain	Prot_kinase_dom	TNIK NTRK2 RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	7.57e-04	489	133	11	IPR000719
Domain	PROTEIN_KINASE_DOM	TNIK NTRK2 RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 FGFR2 CDK11B MAP2K2 CSNK2A3	8.10e-04	493	133	11	PS50011
Domain	ZnF_UBR1	UBR2 UBR4	1.03e-03	7	133	2	SM00396
Domain	ZF_UBR	UBR2 UBR4	1.03e-03	7	133	2	PS51157
Domain	zf-UBR	UBR2 UBR4	1.03e-03	7	133	2	PF02207
Domain	Znf_UBR	UBR2 UBR4	1.03e-03	7	133	2	IPR003126
Domain	Ser/Thr_kinase_AS	TNIK RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 CDK11B MAP2K2 CSNK2A3	1.05e-03	357	133	9	IPR008271
Domain	S_TKc	TNIK RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 CDK11B MAP2K2 CSNK2A3	1.09e-03	359	133	9	SM00220
Domain	PROTEIN_KINASE_ST	TNIK RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 CDK11B MAP2K2 CSNK2A3	1.16e-03	362	133	9	PS00108
Domain	Protein_kinase_ATP_BS	TNIK NTRK2 RPS6KA2 TAOK3 CSNK2A1 CSNK2A2 FGFR2 MAP2K2 CSNK2A3	1.59e-03	379	133	9	IPR017441
Domain	Pkinase	TNIK RPS6KA2 CDK11A TAOK3 CSNK2A1 CSNK2A2 CDK11B MAP2K2 CSNK2A3	1.64e-03	381	133	9	PF00069
Domain	VHS	STAM2 STAM	1.75e-03	9	133	2	PS50179
Domain	VHS	STAM2 STAM	1.75e-03	9	133	2	PF00790
Domain	VHS	STAM2 STAM	1.75e-03	9	133	2	SM00288
Domain	VHS_dom	STAM2 STAM	1.75e-03	9	133	2	IPR002014
Domain	ITAM_1	STAM2 STAM	2.18e-03	10	133	2	PS51055
Domain	Phos_immunorcpt_sig_ITAM	STAM2 STAM	2.18e-03	10	133	2	IPR003110
Domain	GDS_CDC24_CS	ABR PLEKHG1 ARHGEF10	2.68e-03	39	133	3	IPR001331
Domain	FA	EPB41L3 EPB41	3.73e-03	13	133	2	PF08736
Domain	FERM-adjacent	EPB41L3 EPB41	3.73e-03	13	133	2	IPR014847
Domain	FA	EPB41L3 EPB41	3.73e-03	13	133	2	SM01195
Domain	WD40_repeat_dom	KNTC1 UBR4 SEC31A SEC31B ARHGEF10 BOP1 TBL1X	5.43e-03	297	133	7	IPR017986
Domain	HMG_box	SOX1 SOX2 LEF1	6.38e-03	53	133	3	PF00505
Domain	HMG_BOX_2	SOX1 SOX2 LEF1	6.72e-03	54	133	3	PS50118
Domain	HMG	SOX1 SOX2 LEF1	6.72e-03	54	133	3	SM00398
Domain	-	SOX1 SOX2 LEF1	7.07e-03	55	133	3	1.10.30.10
Pathway	REACTOME_GLUCURONIDATION	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	6.52e-07	24	101	5	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	8.10e-07	25	101	5	M17787
Pathway	REACTOME_ASPIRIN_ADME	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.49e-05	44	101	5	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.66e-05	45	101	5	MM15694
Pathway	REACTOME_PREDNISONE_ADME	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.98e-05	23	101	4	MM16639
Pathway	WP_GLUCURONIDATION	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.80e-05	25	101	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.80e-05	25	101	4	M605
Pathway	WP_GLUCURONIDATION	UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.29e-05	26	101	4	M39404
Pathway	REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE	SOX1 SOX2 ZNF521	4.13e-05	10	101	3	M48036
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT1A4 UGT1A3 UGT2B4 UGT2B17	4.45e-05	28	101	4	M19580
Pathway	REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE	SOX1 SOX2 ZNF521	5.65e-05	11	101	3	M48031
Pathway	KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT	CSNK2A1 CSNK2A2 CSNK2A3	9.69e-05	13	101	3	M47763
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION	CSNK2A1 CSNK2A2 FURIN	1.87e-04	16	101	3	M48235
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.05e-04	41	101	4	M7399
Pathway	BIOCARTA_PDZS_PATHWAY	PCLO SPTBN1 EPB41	2.69e-04	18	101	3	M22001
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	SOX2 ZNF613 ZNF473 ZNF705EP CASP2 ZNF521 ZNF208 ZNF621 ZNF772 ZNF519 ZNF705G ZNF419 PAPOLA ZNF257 CCNE2 CSNK2A1 ZNF655 CSNK2A2 FURIN ZNF99 LEF1 TBL1X	2.72e-04	1387	101	22	M734
Pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	CSNK2A1 CSNK2A2 MAP2K2	3.18e-04	19	101	3	MM15113
Pathway	KEGG_TIGHT_JUNCTION	EPB41L3 PARD6B MAGI2 CSNK2A1 CSNK2A2 EPB41	3.68e-04	132	101	6	M11355
Pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	CSNK2A1 CSNK2A2 MAP2K2	4.32e-04	21	101	3	M878
Pathway	KEGG_PROSTATE_CANCER	CREB5 CCNE2 FGFR2 MAP2K2 LEF1	4.41e-04	89	101	5	M13191
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT1A4 UGT1A3 UGT2B4 UGT2B17	4.79e-04	51	101	4	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT1A4 UGT1A3 UGT2B4 UGT2B17	5.16e-04	52	101	4	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT1A4 UGT1A3 UGT2B4 UGT2B17	6.40e-04	55	101	4	M14933
Pathway	KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I	CSNK2A1 CSNK2A2	7.48e-04	6	101	2	M47878
Pathway	WP_BREAST_CANCER_PATHWAY	BRCA2 CSNK2A1 CSNK2A2 MAP2K2 CSNK2A3 LEF1	8.32e-04	154	101	6	M39739
Pubmed	The DNA sequence of human chromosome 7.	CTAGE9 PDK4 PCLO AGR2 CASP2 SOSTDC1 TRRAP CREB5 MAGI2 ZNF655 CTAGE8 CTAGE4 TBX20	4.30e-08	441	144	13	12853948
Pubmed	Isolation and characterization of human cDNA clones encoding the alpha and the alpha' subunits of casein kinase II.	CSNK2A1 CSNK2A2 CSNK2A3	6.95e-08	3	144	3	2174700
Pubmed	Mapping of the human casein kinase II catalytic subunit genes: two loci carrying the homologous sequences for the alpha subunit.	CSNK2A1 CSNK2A2 CSNK2A3	6.95e-08	3	144	3	1766873
Pubmed	Human transcription factor protein interaction networks.	SOX2 NEPRO DTNA SPTBN1 UBR4 TRPS1 ZNF521 CDK11A TRRAP ZBTB14 ZNF260 RESF1 ZNF592 ATXN7 CSNK2A1 CSNK2A2 HELZ HCFC2 PBX1 PBX2 IMMT TBL1X	1.12e-07	1429	144	22	35140242
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.36e-07	12	144	4	20308471
Pubmed	A TALE/HOX code unlocks WNT signalling response towards paraxial mesoderm.	SOX2 PBX1 PBX2 LEF1	1.36e-07	12	144	4	34446717
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NEPRO TBC1D30 NEBL AUP1 SYNE1 TRPS1 CDK11A APP SRFBP1 TRRAP DNAJC2 PARD6B ZNF592 ATXN7 CSNK2A1 CSNK2A2 EIF5 HELZ BOP1 HCFC2 IMMT EPB41	2.48e-07	1497	144	22	31527615
Pubmed	STAM adaptor proteins interact with COPII complexes and function in ER-to-Golgi trafficking.	STAM2 SEC31A STAM	2.77e-07	4	144	3	19054391
Pubmed	cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development.	CTAGE9 NTRK2 SEC31A CTAGE8	3.71e-07	15	144	4	30224460
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZNF473 SYNE1 SPTBN1 UBR4 TRPS1 ZNF521 SEC31A STAM APP SEC31B MAGI2 PTPRK ARHGEF10 SLF2 ZNF592 ZNF655 PBX1 CADPS2 PBX2 IMMT	3.78e-07	1285	144	20	35914814
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STAM2 RPS6KA2 CARMIL1 PARP8 SPTBN1 DNM1L EPB41L3 PLEKHG1 VPS13D RESF1 ARHGEF10 SLF2 EIF5 HELZ MAP2K2 EPB41	6.25e-07	861	144	16	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CARMIL1 SPTBN1 CDK11A TRRAP ZFX TUBGCP6 PAPOLA ZNF592 ATXN7 CSNK2A1 CSNK2A2 GZMB HELZ CDK11B MAP2K2	8.52e-07	774	144	15	15302935
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CARMIL1 SPTBN1 CDK11A EPB41L3 TRRAP VPS13D TAOK3 ZNF592 CSNK2A1 CDK11B ZNF99 CSNK2A3	1.20e-06	497	144	12	36774506
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ABR AUP1 DTNA RPS6KA2 MRPL30 CDK11A TRRAP TAOK3 CCNE2 CSNK2A1 CSNK2A2 BOP1 FGFR2 CDK11B MAP2K2 CSNK2A3	1.29e-06	910	144	16	36736316
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX1 SOX2 ZNF473 ZBTB48 TRPS1 ZNF208 ZNF236 ZNF260 ZNF419 ZNF592 ZNF655 PBX2 TBX20 ZNF99 LEF1	1.45e-06	808	144	15	20412781
Pubmed	FAM20B-catalyzed glycosaminoglycans control murine tooth number by restricting FGFR2b signaling.	SOX2 SOSTDC1 FGFR2 LEF1	1.95e-06	22	144	4	32664967
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KNTC1 DTNA SYNE1 PARP8 PCLO SPTBN1 UBR4 CTAGE6 EPB41L3 SEPHS1 NRXN1 ATXN7 FAM186A CTAGE8 CTAGE15 CTAGE4 CADPS2 SPAG17 TSACC IMMT	2.23e-06	1442	144	20	35575683
Pubmed	Interaction network of human early embryonic transcription factors.	TRPS1 ZNF521 APP ZBTB14 RESF1 ASXL3 PBX1 PBX2 IMMT TBL1X	2.24e-06	351	144	10	38297188
Pubmed	A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.	CSNK2A1 CSNK2A2 CSNK2A3	2.40e-06	7	144	3	11239457
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK ABR SYNE1 NTRK2 RPS6KA2 SPTBN1 UBR4 DNM1L SEC31A EPB41L3 MAGI2 DZANK1 NRXN1 CSNK2A1 CSNK2A2 TBL1X	2.66e-06	963	144	16	28671696
Pubmed	CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).	UBR4 CDK11A CSNK2A1 CSNK2A2 CDK11B	3.34e-06	55	144	5	23178491
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT1A4 UGT1A3 UGT2B17	3.83e-06	8	144	3	22579593
Pubmed	p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.	CSNK2A1 CSNK2A2 CSNK2A3	3.83e-06	8	144	3	12393879
Pubmed	The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.	UGT1A3 UGT2B4 UGT2B17	3.83e-06	8	144	3	18719240
Pubmed	Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.	UGT1A3 UGT2B4 UGT2B17	3.83e-06	8	144	3	20142249
Pubmed	A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle.	CKM PBX1 PBX2	5.73e-06	9	144	3	18676817
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	RPS6KA2 SPTBN1 CDK11A DSN1 PARD6B CCNE2 CSNK2A1 CSNK2A2 MAP2K2 IMMT	7.23e-06	401	144	10	25852190
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	ABR ZBTB48 PARP8 SPTBN1 TRPS1 CDK11A DNM1L SEC31A APP ZNF236 ZBTB14 TGFB1I1 PAPOLA EIF5 MPPE1	7.43e-06	925	144	15	28986522
Pubmed	Phase transition specified by a binary code patterns the vertebrate eye cup.	SOX2 FGFR2 MAP2K2 LEF1	8.13e-06	31	144	4	34757798
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	STAM2 ABR AUP1 DTNA CARMIL1 SPTBN1 DNM1L SEC31A STAM EPB41L3 EIF5 IMMT EPB41	8.47e-06	708	144	13	39231216
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	TNIK RPS6KA2 SPTBN1 SYBU EPB41L3 CSNK2A1 CSNK2A2 CDK11B	9.20e-06	246	144	8	15345747
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	TNIK ABR SYNE1 RPS6KA2 SPTBN1 EPB41L3 DZANK1 NRXN1	1.06e-05	251	144	8	27507650
Pubmed	Ubiquitin-specific protease 8 deubiquitinates Sec31A and decreases large COPII carriers and collagen IV secretion.	STAM2 SEC31A STAM	1.12e-05	11	144	3	29604273
Pubmed	The cortical hem lacks stem cell potential despite expressing SOX9 and HOPX.	SOX1 SOX2 LEF1	1.12e-05	11	144	3	36067402
Pubmed	Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.	UGT1A4 UGT1A3 UGT2B4	1.49e-05	12	144	3	18161889
Pubmed	Proliferative and transcriptional identity of distinct classes of neural precursors in the mammalian olfactory epithelium.	SOX2 PBX1 PBX2	1.49e-05	12	144	3	20573694
Pubmed	Casein kinase 2 and microtubules control axon initial segment formation.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	20850541
Pubmed	Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	12568341
Pubmed	CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression.	CSNK2A1 EIF5	1.70e-05	2	144	2	16227438
Pubmed	Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2.	CSNK2A1 CSNK2A3	1.70e-05	2	144	2	14646071
Pubmed	Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	11704824
Pubmed	Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.	UGT1A4 UGT1A3	1.70e-05	2	144	2	24641623
Pubmed	S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.	DNM1L APP	1.70e-05	2	144	2	19342591
Pubmed	Vps13D Encodes a Ubiquitin-Binding Protein that Is Required for the Regulation of Mitochondrial Size and Clearance.	DNM1L VPS13D	1.70e-05	2	144	2	29307555
Pubmed	Identification of a phosphatase activity, toward the phosphopeptide pyroGlu-Asp-Asp-Ser(p)-Asp-Glu-Glu-Asn, in nuclear extract from HL-60 promyelocitic leukaemia cells.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	10970045
Pubmed	The 4.1B cytoskeletal protein regulates the domain organization and sheath thickness of myelinated axons.	EPB41L3 EPB41	1.70e-05	2	144	2	23109359
Pubmed	Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	21739153
Pubmed	Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.	CSNK2A1 CSNK2A3	1.70e-05	2	144	2	12860116
Pubmed	SOX 1, contrary to SOX 2, suppresses proliferation, migration, and invasion in human laryngeal squamous cell carcinoma by inhibiting the Wnt/β-catenin pathway.	SOX1 SOX2	1.70e-05	2	144	2	26040764
Pubmed	Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	21769451
Pubmed	CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization.	CDK11A CDK11B	1.70e-05	2	144	2	28101846
Pubmed	Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.	CDK11A CDK11B	1.70e-05	2	144	2	10882096
Pubmed	Structure and expression of the human p58clk-1 protein kinase chromosomal gene.	CDK11A CDK11B	1.70e-05	2	144	2	1639388
Pubmed	Identification of four genomic loci highly related to casein-kinase-2-alpha cDNA and characterization of a casein kinase-2-alpha pseudogene within the mouse genome.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	1497660
Pubmed	Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.	EPB41L3 EPB41	1.70e-05	2	144	2	15731777
Pubmed	Protein expression pattern of CDK11(p58) during testicular development in the mouse.	CDK11A CDK11B	1.70e-05	2	144	2	15792358
Pubmed	Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	23290496
Pubmed	Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	29243286
Pubmed	CK2 activity is crucial for proper glucagon expression.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	38503901
Pubmed	Subcellular localization of protein kinase CK2. A key to its function?	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	10994779
Pubmed	Protein 4.1B contributes to the organization of peripheral myelinated axons.	SPTBN1 EPB41L3	1.70e-05	2	144	2	21966409
Pubmed	CK2 phosphorylates Sec31 and regulates ER-To-Golgi trafficking.	SEC31A CSNK2A1	1.70e-05	2	144	2	23349870
Pubmed	Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms.	CDK11A CDK11B	1.70e-05	2	144	2	8195233
Pubmed	Predominance of CK2α over CK2α' in the mammalian brain.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	21761202
Pubmed	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	BRCA2 FGFR2	1.70e-05	2	144	2	21060860
Pubmed	Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation.	PBX1 PBX2	1.70e-05	2	144	2	7910944
Pubmed	Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.	CSNK2A1 CDK11B	1.70e-05	2	144	2	25837326
Pubmed	Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.	SOX2 TRPS1	1.70e-05	2	144	2	30315105
Pubmed	Assignment of casein kinase 2 alpha sequences to two different human chromosomes.	CSNK2A1 CSNK2A3	1.70e-05	2	144	2	1577469
Pubmed	Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	10471512
Pubmed	Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.	DNM1L APP	1.70e-05	2	144	2	21459773
Pubmed	Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma.	CDK11A CDK11B	1.70e-05	2	144	2	7920654
Pubmed	CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	26598688
Pubmed	Regulated expression of a cell division control-related protein kinase during development.	CDK11A CDK11B	1.70e-05	2	144	2	2069872
Pubmed	A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand.	CDK11A CDK11B	1.70e-05	2	144	2	7528743
Pubmed	Protein kinase CK2 in mammary gland tumorigenesis.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	11423974
Pubmed	Localization of the expressed human p58 protein kinase chromosomal gene to chromosome 1p36 and a highly related sequence to chromosome 15.	CDK11A CDK11B	1.70e-05	2	144	2	1774066
Pubmed	Pbx1 is required for adult subventricular zone neurogenesis.	PBX1 PBX2	1.70e-05	2	144	2	27226325
Pubmed	Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	33363536
Pubmed	Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	11827170
Pubmed	Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival.	STAM2 STAM	1.70e-05	2	144	2	12446783
Pubmed	CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.	CDK11A CDK11B	1.70e-05	2	144	2	30722725
Pubmed	Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	7896000
Pubmed	Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	33944995
Pubmed	HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription.	TGFB1I1 LEF1	1.70e-05	2	144	2	16291758
Pubmed	Mitochondrial fission is a critical modulator of mutant APP-induced neural toxicity.	DNM1L APP	1.70e-05	2	144	2	33639169
Pubmed	The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.	CDK11A CDK11B	1.70e-05	2	144	2	27049727
Pubmed	Molecular cloning of the human casein kinase II alpha subunit.	CSNK2A1 CSNK2A3	1.70e-05	2	144	2	2752008
Pubmed	Structure and sequence of an intronless gene for human casein kinase II-alpha subunit.	CSNK2A1 CSNK2A3	1.70e-05	2	144	2	8420794
Pubmed	Increased O-GlcNAcylation of Drp1 by amyloid-beta promotes mitochondrial fission and dysfunction in neuronal cells.	DNM1L APP	1.70e-05	2	144	2	33422108
Pubmed	Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development.	CDK11A CDK11B	1.70e-05	2	144	2	15060143
Pubmed	N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases.	UGT1A4 UGT1A3	1.70e-05	2	144	2	14570768
Pubmed	Structural basis of CX-4945 binding to human protein kinase CK2.	CSNK2A1 CSNK2A2	1.70e-05	2	144	2	21093442
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	EPB41L3 MAGI2 VPS13D RESF1 NRXN1 CADPS2	1.77e-05	130	144	6	12421765
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SOX2 ZNF473 ZBTB48 TRPS1 ZNF519 ZNF236 TGFB1I1 BRCA2 ZNF592 PBX1 PBX2 TBX20 LEF1 TBL1X	1.81e-05	877	144	14	20211142
Pubmed	New insights into potential functions for the protein 4.1 superfamily of proteins in kidney epithelium.	APP EPB41L3 EPB41	1.93e-05	13	144	3	16368544
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	TNIK SYNE1 PCLO SPTBN1 DNM1L EPB41L3 DZANK1 CSNK2A2	2.40e-05	281	144	8	28706196
Pubmed	Dentate gyrus development requires a cortical hem-derived astrocytic scaffold.	SOX1 SOX2 LEF1	2.45e-05	14	144	3	33393905
Pubmed	Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis.	DSPP SOSTDC1 LEF1	2.45e-05	14	144	3	18022614
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A4 UGT1A3 UGT2B4	2.45e-05	14	144	3	9295054
Interaction	GPATCH2L interactions	ZNF473 ZBTB48 CDK11A APP CSNK2A1 CSNK2A2 CDK11B CSNK2A3	3.65e-08	72	140	8	int:GPATCH2L
Interaction	TTC3 interactions	SOX2 KIF18A SPTBN1 UBR4 APP DSN1 CSNK2A2 CADPS2 PBX2	2.10e-07	124	140	9	int:TTC3
Interaction	CTAGE1 interactions	CTAGE6 CTAGE8 CTAGE15 CTAGE4	4.54e-07	10	140	4	int:CTAGE1
Interaction	HIRIP3 interactions	CDK11A APP TRRAP CSNK2A1 CSNK2A2 CDK11B CSNK2A3	2.47e-06	87	140	7	int:HIRIP3
Interaction	GPATCH2 interactions	CDK11A CSNK2A1 CSNK2A2 CDK11B CSNK2A3	4.77e-06	36	140	5	int:GPATCH2
Interaction	EIF3CL interactions	RPS6KA2 CDK11A CSNK2A1 CSNK2A2 EIF5 CDK11B CSNK2A3	5.49e-06	98	140	7	int:EIF3CL
Interaction	ABR interactions	ABR APP CSNK2A1 CSNK2A2 CSNK2A3	9.23e-06	41	140	5	int:ABR
Interaction	CEP170 interactions	SOX2 TNIK NEBL CDK11A NRXN1 CSNK2A1 CSNK2A2 INAVA CDK11B MAP2K2 CSNK2A3	1.41e-05	318	140	11	int:CEP170
Interaction	AQP4 interactions	NTRK2 NRXN1 CSNK2A1 CSNK2A2	2.52e-05	25	140	4	int:AQP4
Interaction	CT45A3 interactions	CSNK2A1 CSNK2A2 CSNK2A3	2.67e-05	9	140	3	int:CT45A3
Interaction	F2RL3 interactions	CSNK2A1 CSNK2A2 CSNK2A3	2.67e-05	9	140	3	int:F2RL3
Interaction	CTBP1 interactions	SOX2 TNIK PCLO TRPS1 SEC31A CREB5 RESF1 CSNK2A1 CSNK2A2 FURIN HELZ TBL1X	2.72e-05	406	140	12	int:CTBP1
Interaction	ARRDC3 interactions	TNIK STAM2 ABR DTNA STAM EPB41L3 MAGI2 CSNK2A1 CSNK2A2	2.74e-05	224	140	9	int:ARRDC3
Interaction	TLX1 interactions	SOX2 TRPS1 ZNF260 CSNK2A1 CSNK2A2 PBX1 PBX2 TBL1X	3.11e-05	175	140	8	int:TLX1
Interaction	EFCAB14 interactions	CSNK2A1 CSNK2A2 CSNK2A3	3.80e-05	10	140	3	int:EFCAB14
Interaction	PCGF3 interactions	CDK11A CSNK2A1 CSNK2A2 HELZ CDK11B CSNK2A3	3.89e-05	90	140	6	int:PCGF3
Interaction	MBD3 interactions	SOX2 AGR2 TRPS1 CDK11A TRRAP CSNK2A1 ZNF655 CSNK2A2 CDK11B CSNK2A3	4.17e-05	295	140	10	int:MBD3
Interaction	EIF3F interactions	SOX2 AGR2 CDK11A DNM1L APP CSNK2A1 CSNK2A2 CDK11B CSNK2A3 IMMT	4.29e-05	296	140	10	int:EIF3F
Interaction	COL11A1 interactions	SOX2 APP TRRAP BRCA2	4.63e-05	29	140	4	int:COL11A1
Interaction	ABCE1 interactions	SOX2 KNTC1 AGR2 RANBP6 DNM1L EPB41L3 CSNK2A1 FURIN EIF5 FGFR2 IMMT EPB41	4.86e-05	431	140	12	int:ABCE1
Interaction	SHOX interactions	CSNK2A1 PBX1 PBX2	5.20e-05	11	140	3	int:SHOX
Interaction	ANKRD36C interactions	CSNK2A1 CSNK2A2 CSNK2A3	6.89e-05	12	140	3	int:ANKRD36C
Interaction	PCGF5 interactions	CDK11A CSNK2A1 CSNK2A2 HELZ CDK11B CSNK2A3	7.44e-05	101	140	6	int:PCGF5
Interaction	ZC3H4 interactions	TNIK CDK11A CSNK2A1 CSNK2A2 FURIN CDK11B CSNK2A3	7.62e-05	147	140	7	int:ZC3H4
Interaction	RTF1 interactions	APP EPB41L3 TRRAP CSNK2A1 CSNK2A2 CDK11B CSNK2A3	8.65e-05	150	140	7	int:RTF1
Interaction	IPMK interactions	CSNK2A1 CSNK2A2 CSNK2A3	8.92e-05	13	140	3	int:IPMK
Interaction	HAGHL interactions	CSNK2A1 CSNK2A2 CSNK2A3	8.92e-05	13	140	3	int:HAGHL
Interaction	EIF3C interactions	RPS6KA2 PCLO CDK11A DNAJC2 CSNK2A1 CSNK2A2 EIF5 CDK11B CSNK2A3	9.48e-05	263	140	9	int:EIF3C
Interaction	LMX1B interactions	APP CREB5 PBX1 PBX2	9.88e-05	35	140	4	int:LMX1B
Interaction	CCNL1 interactions	CDK11A APP CSNK2A1 CSNK2A2 CDK11B	1.03e-04	67	140	5	int:CCNL1
Interaction	EPB41L3 interactions	NTRK2 SPTBN1 APP EPB41L3 KANK1 NRXN1 CSNK2A1 CSNK2A2 EPB41	1.22e-04	272	140	9	int:EPB41L3
Interaction	CCT8 interactions	SOX2 PDK4 SYNE1 AGR2 DNM1L APP SEC31B ZBTB14 ZNF705G CSNK2A1 ASXL3 HCFC2 EPB41	1.23e-04	550	140	13	int:CCT8
Interaction	TTLL7 interactions	APP CSNK2A1 CSNK2A2	1.40e-04	15	140	3	int:TTLL7
Interaction	ZNF423 interactions	ZNF473 ZBTB48 ZNF521 APP ZBTB14	1.55e-04	73	140	5	int:ZNF423
Interaction	ARK2N interactions	CDK11A CSNK2A1 CSNK2A2 BOP1 CDK11B CSNK2A3	1.60e-04	116	140	6	int:ARK2N
Interaction	DDX41 interactions	SOX2 RPS6KA2 CDK11A CSNK2A1 CSNK2A2 CDK11B CSNK2A3	1.63e-04	166	140	7	int:DDX41
Interaction	PCDH18 interactions	CSNK2A1 CSNK2A2 CSNK2A3	1.72e-04	16	140	3	int:PCDH18
Interaction	GATAD2A interactions	SOX2 TRPS1 CDK11A ZNF592 CSNK2A1 CSNK2A2 CDK11B CSNK2A3	1.75e-04	224	140	8	int:GATAD2A
Interaction	NMT2 interactions	CDK11A APP CSNK2A1 CSNK2A2 CDK11B	1.87e-04	76	140	5	int:NMT2
Cytoband	7q35	CTAGE6 CTAGE8 CTAGE15 CTAGE4	2.80e-05	55	144	4	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	CTAGE6 CTAGE8 CTAGE15 CTAGE4	5.75e-05	66	144	4	chr7q35
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 ZNF613 ZNF473 ZBTB48 TRPS1 ZNF521 ZNF208 ZNF621 ZNF57 ZNF772 ZNF519 ZNF236 ZBTB14 ZFX ZNF260 ZNF705G ZNF419 ZNF592 ZNF257 ZNF655 ZNF99	1.65e-10	718	97	21	28
GeneFamily	CTAGE family	CTAGE9 CTAGE6 CTAGE8 CTAGE15 CTAGE4	1.15e-08	15	97	5	907
GeneFamily	UDP glucuronosyltransferases	UGT3A1 UGT1A4 UGT1A3 UGT2B4 UGT2B17	7.19e-07	32	97	5	363
GeneFamily	ESCRT-0	STAM2 STAM	8.52e-05	3	97	2	1115
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L3 EPB41	1.70e-04	4	97	2	951
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR2 UBR4	5.88e-04	7	97	2	785
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR PCLO CADPS2	9.40e-04	36	97	3	823
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	ZNF419 RESF1 UGT2B17	2.59e-03	51	97	3	870
GeneFamily	Lysine acetyltransferases\|ATAC complex\|SAGA complex\|GCN5 related N-acetyltransferases	TRRAP ATXN7	3.68e-03	17	97	2	1059
GeneFamily	SRY-boxes	SOX1 SOX2	4.59e-03	19	97	2	757
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR PLEKHG1 ARHGEF10	5.36e-03	66	97	3	722
GeneFamily	Cyclin dependent kinases	CDK11A CDK11B	8.51e-03	26	97	2	496
GeneFamily	TALE class homeoboxes and pseudogenes	PBX1 PBX2	8.51e-03	26	97	2	526
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	CTAGE9 SPTBN1 DNM1L CTAGE6 ZNF519 ZFX PLEKHG1 MOXD1 PTPRK EIF5 CTAGE15 CTAGE4 TBX20 LEF1	3.65e-06	587	141	14	M40869
Coexpression	GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP	PARP8 DNAJC2 TAOK3 PAPOLA CSNK2A2 FURIN BOP1 LEF1	1.33e-05	200	141	8	M6305
Coexpression	GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	NEPRO AUP1 CARMIL1 BBS10 BOP1 PBX2 TBL1X	2.34e-05	157	141	7	M8788
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	NEBL SYNE1 SPTBN1 AGR2 PARD6B PTPRK FGFR2 PBX1 CADPS2	1.45e-08	195	143	9	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	NEBL SYNE1 SPTBN1 AGR2 PARD6B PTPRK FGFR2 PBX1 CADPS2	1.45e-08	195	143	9	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	ANO2 NTRK2 SPTBN1 PLEKHG1 TMTC1 PTPRK ARHGEF10 CADPS2	1.91e-07	190	143	8	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	NEBL SYNE1 SPTBN1 AGR2 PARD6B KANK1 PTPRK CADPS2	2.07e-07	192	143	8	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	NEBL SYNE1 AGR2 PARD6B KANK1 PTPRK FGFR2 CADPS2	2.32e-07	195	143	8	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	ANO2 NEBL SYNE1 SPTBN1 MAGI2 PLEKHG1 PTPRK LEF1	2.82e-07	200	143	8	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	ANO2 NEBL SYNE1 SPTBN1 MAGI2 PLEKHG1 PTPRK LEF1	2.82e-07	200	143	8	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	ANO2 NEBL SYNE1 SPTBN1 MAGI2 PLEKHG1 PTPRK LEF1	2.82e-07	200	143	8	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	ANO2 NEBL SYNE1 SPTBN1 MAGI2 PLEKHG1 PTPRK LEF1	2.82e-07	200	143	8	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	ANO2 NEBL SYNE1 SPTBN1 MAGI2 PLEKHG1 PTPRK LEF1	2.82e-07	200	143	8	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	ANO2 NEBL SYNE1 SPTBN1 MAGI2 PLEKHG1 PTPRK LEF1	2.82e-07	200	143	8	7136936d05ab344a560cf159684c881063b5430d
ToppCell	IIH-Treg\|IIH / Condition, Cell_class and T cell subcluster	NEBL STAM GPR179 RESF1 BRCA2 LEF1 EPB41	6.50e-07	153	143	7	17704e18833812fcf2a2727b1e3f8a9984ba5b59
ToppCell	IIH-Treg-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	NEBL STAM GPR179 RESF1 BRCA2 LEF1 EPB41	6.80e-07	154	143	7	d2211a892654b92decb208969040920f7ae8ba1e
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SYNE1 SPTBN1 SOSTDC1 APP PLEKHG1 ARHGEF10 CADPS2	2.00e-06	181	143	7	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNE1 SPTBN1 SOSTDC1 APP PLEKHG1 ARHGEF10 CADPS2	2.67e-06	189	143	7	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	NEBL AGR2 SYBU PARD6B PTPRK FGFR2 CADPS2	2.67e-06	189	143	7	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	TNIK FBXO40 NEBL DTNA PDK4 KANK1 RNF207	2.76e-06	190	143	7	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	NEBL AGR2 PARD6B KANK1 PTPRK FGFR2 CADPS2	2.76e-06	190	143	7	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ANO2 NTRK2 SPTBN1 PLEKHG1 TMTC1 ARHGEF10 CADPS2	2.76e-06	190	143	7	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Control-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	ANO2 SYNE1 SPTBN1 PLEKHG1 TMTC1 PTPRK CADPS2	2.86e-06	191	143	7	c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	NEBL AGR2 SYBU PARD6B PTPRK FGFR2 CADPS2	2.86e-06	191	143	7	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	ANO2 SYNE1 SPTBN1 PLEKHG1 TMTC1 PTPRK CADPS2	2.86e-06	191	143	7	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANO2 SPTBN1 APP PLEKHG1 TMTC1 ARHGEF10 CADPS2	3.06e-06	193	143	7	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NEBL SYNE1 PARD6B KANK1 PTPRK FGFR2 CADPS2	3.17e-06	194	143	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK NEBL SYNE1 CARMIL1 KANK1 PTPRK CADPS2	3.17e-06	194	143	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 SYNE1 SPTBN1 ZNF521 PLEKHG1 TMTC1 PBX1	3.17e-06	194	143	7	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	NEBL SYNE1 SPTBN1 PTPRK PBX1 CADPS2 SPAG17	3.28e-06	195	143	7	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	NEBL SYNE1 SPTBN1 PTPRK PBX1 CADPS2 SPAG17	3.28e-06	195	143	7	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NEBL SYNE1 PARD6B KANK1 PTPRK FGFR2 CADPS2	3.28e-06	195	143	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANO2 SPTBN1 APP PLEKHG1 TMTC1 ARHGEF10 CADPS2	3.39e-06	196	143	7	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SYNE1 RPS6KA2 SPTBN1 SOSTDC1 APP PLEKHG1 CADPS2	3.39e-06	196	143	7	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TNIK SYNE1 SPTBN1 RESF1 GZMB LEF1 EPB41	3.51e-06	197	143	7	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	ANO2 NTRK2 SPTBN1 PLEKHG1 TMTC1 PTPRK CADPS2	3.51e-06	197	143	7	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	TNIK PCLO SPTBN1 SYBU APP NRXN1 PBX1	3.75e-06	199	143	7	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	10x_3'_v2v3-Neoplastic\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX2 DTNA NTRK2 SPTBN1 APP NRXN1 PBX1	3.87e-06	200	143	7	e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL RPS6KA2 CREB5 MAGI2 GZMB RNF207	1.02e-05	153	143	6	3b1b0cc8e9dd2b1484649789330713282ee44414
ToppCell	390C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NTRK2 AGR2 KIAA0586 MRPL30 C8orf48 ZNF519	1.41e-05	162	143	6	45be019b50e3727fc9d3fad2ff78e74e4f2d746b
ToppCell	390C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NTRK2 AGR2 KIAA0586 MRPL30 C8orf48 ZNF519	1.41e-05	162	143	6	fbb0cc2b1434a340dc35058b77c73ea61004c252
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	DSN1 CFAP20DC TEX30 BRCA2 PTPRK LEF1	1.62e-05	166	143	6	f4698fd08965936d51695d571bd10fb77330d916
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 SPTBN1 APP PLEKHG1 TMTC1 PBX1	1.79e-05	169	143	6	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	DSN1 CFAP20DC TEX30 BRCA2 PBX1 LEF1	1.98e-05	172	143	6	e9b97f37bb1732ad9aa89c5e9b513d14022801ac
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	ANO2 NTRK2 SPTBN1 PLEKHG1 TMTC1 ARHGEF10	2.64e-05	181	143	6	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DTNA CARMIL1 TRPS1 ZNF521 EPB41L3 LEF1	2.72e-05	182	143	6	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX2 ZNF473 DTNA SOSTDC1 CFAP100 NRXN1	2.72e-05	182	143	6	c00e503f442d44fbae73c5e2dc85be69e294e67a
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX2 TNIK DTNA SOSTDC1 CFAP100 MOXD1	2.81e-05	183	143	6	876b4f128c2168fdae7488201ff44f19c06c8415
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX2 TNIK DTNA SOSTDC1 CFAP100 MOXD1	2.81e-05	183	143	6	b190b650e61b1b20baf5e42d04acac82d3fd1400
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	ANO2 SYNE1 ZNF521 PLEKHG1 TMTC1 PBX1	2.81e-05	183	143	6	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK NEBL KANK1 PTPRK FGFR2 CADPS2	2.81e-05	183	143	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	NEBL SYNE1 PARD6B KANK1 PTPRK CADPS2	2.81e-05	183	143	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	10x5'-blood-Lymphocytic_T_CD4-Tregs\|blood / Manually curated celltypes from each tissue	TNIK NEBL STAM RESF1 LEF1 EPB41	2.90e-05	184	143	6	22c15ce30171c687ab564f4383ae74d38b759272
ToppCell	normal-na-Lymphocytic-lymphocyte-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SEC31B ZNF260 BRCA2 SLF2 CCNE2 MAP2K2	2.90e-05	184	143	6	2c286712428662bc4589dc5ac4011bf7ed403cb5
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTNA SYNE1 SOSTDC1 TGFB1I1 MAGI2 PBX1	2.98e-05	185	143	6	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	SYNE1 SPTBN1 SOSTDC1 APP PLEKHG1 CADPS2	2.98e-05	185	143	6	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	NEBL PARD6B KANK1 PTPRK FGFR2 CADPS2	3.08e-05	186	143	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	KIF18A DTNA AGR2 SOSTDC1 RNF207 EPB41	3.08e-05	186	143	6	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK DTNA CREB5 KANK1 PTPRK FGFR2	3.08e-05	186	143	6	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	ANO2 NTRK2 SPTBN1 APP PLEKHG1 TMTC1	3.17e-05	187	143	6	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	SYNE1 SPTBN1 SOSTDC1 APP PLEKHG1 CADPS2	3.17e-05	187	143	6	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	Control-Endothelial_cells\|Control / group, cell type (main and fine annotations)	ANO2 SPTBN1 APP PLEKHG1 TMTC1 ARHGEF10	3.27e-05	188	143	6	3953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PARP8 ZNF521 FGFR2 PBX1 LEF1 TBL1X	3.27e-05	188	143	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	FBXO40 NEBL DTNA PDK4 KANK1 RNF207	3.36e-05	189	143	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANO2 SYNE1 SPTBN1 PLEKHG1 TMTC1 CADPS2	3.36e-05	189	143	6	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 ABR RPS6KA2 PLEKHG1 TMTC1 LEF1	3.36e-05	189	143	6	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SOX2 PDK4 EPB41L3 NRXN1 INAVA FGFR2	3.46e-05	190	143	6	47e07ea22733306d8885ee9e5f0b033e2f5e2afb
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SOX2 PDK4 EPB41L3 NRXN1 INAVA FGFR2	3.46e-05	190	143	6	261b8afddfdcba4f70b50df126cef7ad00a0aae0
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	ANO2 PDK4 SYNE1 NTRK2 PTPRK CADPS2	3.46e-05	190	143	6	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTRK2 SPTBN1 ZNF521 SYBU PLEKHG1 ARHGEF10	3.46e-05	190	143	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	FBXO40 NEBL DTNA PDK4 KANK1 RNF207	3.46e-05	190	143	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABR SPTBN1 ZNF521 PLEKHG1 TMTC1 PBX1	3.57e-05	191	143	6	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK NEBL KANK1 PTPRK FGFR2 CADPS2	3.57e-05	191	143	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTNA SYNE1 SOSTDC1 TGFB1I1 MAGI2 PBX1	3.57e-05	191	143	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYNE1 SPTBN1 SOSTDC1 APP PLEKHG1 CADPS2	3.57e-05	191	143	6	f229abf69a1217194f74b0502486907e07dba989
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEBL PARD6B KANK1 PTPRK FGFR2 CADPS2	3.57e-05	191	143	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ANO2 SYNE1 APP PLEKHG1 TMTC1 CADPS2	3.57e-05	191	143	6	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	NEBL PARD6B KANK1 PTPRK FGFR2 CADPS2	3.67e-05	192	143	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	NEBL AGR2 PARD6B PTPRK FGFR2 SPAG17	3.67e-05	192	143	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	ANO2 SYNE1 APP PLEKHG1 TMTC1 CADPS2	3.67e-05	192	143	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	NEBL RPS6KA2 PCLO KANK1 PTPRK CADPS2	3.67e-05	192	143	6	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	NEBL PARD6B KANK1 PTPRK FGFR2 CADPS2	3.67e-05	192	143	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 ABR ZNF521 PLEKHG1 TMTC1 PBX1	3.67e-05	192	143	6	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK SYNE1 KANK1 PTPRK FGFR2 CADPS2	3.78e-05	193	143	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	IPF-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	ANO2 SPTBN1 PLEKHG1 TMTC1 PTPRK CADPS2	3.78e-05	193	143	6	d7750a7575ef257963b7f1c64fa67c52dbff797b
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ANO2 SYNE1 SPTBN1 PLEKHG1 ARHGEF10 CADPS2	3.78e-05	193	143	6	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK SYNE1 KANK1 PTPRK FGFR2 CADPS2	3.78e-05	193	143	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 ZNF521 EPB41L3 PLEKHG1 TMTC1 PBX1	3.78e-05	193	143	6	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 ABR ZNF521 PLEKHG1 TMTC1 PBX1	3.78e-05	193	143	6	52e918884877b6659cdca0496390e440f73694a9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 SPTBN1 ZNF521 PLEKHG1 TMTC1 PBX1	3.89e-05	194	143	6	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK NEBL CREB5 PARD6B KANK1 PTPRK	3.89e-05	194	143	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 SPTBN1 ZNF521 APP PLEKHG1 PBX1	3.89e-05	194	143	6	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PCLO PARD6B KANK1 FGFR2 SPAG17	3.89e-05	194	143	6	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	IPF-Endothelial-VE_Capillary_B\|IPF / Disease state, Lineage and Cell class	ANO2 SPTBN1 PLEKHG1 TMTC1 PTPRK CADPS2	3.89e-05	194	143	6	169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNIK NEBL MAGI2 MOXD1 SLF2 UGT2B4	3.89e-05	194	143	6	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	ANO2 SPTBN1 ZNF521 PLEKHG1 TMTC1 CADPS2	3.89e-05	194	143	6	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	TNIK STAM2 AGR2 TGFB1I1 PARD6B CADPS2	3.89e-05	194	143	6	4c40d6b50675eae52c419d69e719a9223df02ae3
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	TNIK STAM2 AGR2 TGFB1I1 PARD6B CADPS2	3.89e-05	194	143	6	99a90de637e3babec2131cdd9f05ea965d8a8f30
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABR SYNE1 SPTBN1 ZNF521 TMTC1 PBX1	3.89e-05	194	143	6	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 SPTBN1 ZNF521 PLEKHG1 TMTC1 PBX1	3.89e-05	194	143	6	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	IPF-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	ANO2 ZNF521 PLEKHG1 TMTC1 PTPRK CADPS2	4.01e-05	195	143	6	120296531bbc8080dcabacbd64733cc1dc34603a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANO2 ABR RPS6KA2 PLEKHG1 TMTC1 LEF1	4.01e-05	195	143	6	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	facs-Tongue\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX2 NTRK2 MOXD1 KANK1 INAVA FGFR2	4.01e-05	195	143	6	77128895db9221a64a171082d468ebcd6380c936
Drug	Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	KIF18A ABR DSPP DTNA APP DSN1 ZFX ZNF419 NBAS KANK1 EIF5 HELZ	3.40e-09	198	139	12	6271_DN
Drug	C1 11-32	UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.81e-06	18	139	4	CID000443077
Drug	C11131	UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.81e-06	18	139	4	CID000443076
Drug	Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	STAM2 DTNA NTRK2 PCLO SPTBN1 KIAA0586 SYBU APP ZNF419	3.82e-06	199	139	9	5545_UP
Drug	1,3-bis(diphenylphosphino)propane	DSPP SYNE1 SPAG17	4.39e-06	6	139	3	CID000081219
Drug	AC1L1OBF	UGT1A4 UGT1A3 UGT2B4 UGT2B17	5.97e-06	20	139	4	CID000032736
Drug	estriol-16-glucuronide	UGT1A4 UGT1A3 UGT2B4 UGT2B17	7.34e-06	21	139	4	CID000122281
Drug	ranirestat	UGT1A4 UGT1A3 UGT2B4	7.66e-06	7	139	3	ctd:C115070
Drug	estradiol-3-glucuronide	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.08e-05	23	139	4	CID000066651
Drug	Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; HL60; HT_HG-U133A	TNIK KIF18A STAM2 RPS6KA2 TRPS1 ARHGEF10 ATXN7 LEF1	1.65e-05	182	139	8	2576_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	SYNE1 RPS6KA2 SPTBN1 APP PAPOLA BRCA2 SLF2 MPPE1	1.72e-05	183	139	8	7088_DN
Drug	licochalcone A	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.09e-05	27	139	4	ctd:C070840
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	ABR ZNF473 TBC1D30 CASP2 VPS13D CCNE2 FGFR2 PBX1	2.34e-05	191	139	8	4454_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	ZBTB48 TBC1D30 NEBL KIAA0586 CASP2 PARD6B PBX1 MPPE1	2.52e-05	193	139	8	5985_DN
Drug	Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SPTBN1 CASP2 SYBU ZFX PARD6B BRCA2 FURIN FGFR2	2.61e-05	194	139	8	2891_DN
Drug	Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; HL60; HT_HG-U133A	STAM2 ZNF142 ABR DTNA TRPS1 APP BRCA2 TBL1X	2.71e-05	195	139	8	1267_DN
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A	TBC1D30 NEBL DSPP SYNE1 CREB5 ZBTB14 ZFX BRCA2	2.71e-05	195	139	8	6662_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TBC1D30 NEBL DTNA CASP2 ZNF236 ZNF592 EIF5 MPPE1	2.71e-05	195	139	8	2649_DN
Drug	7-hydroxycoumarin glucuronide	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.81e-05	29	139	4	CID000125641
Drug	7-hydroxy-4-trifluoromethylcoumarin	UGT1A4 UGT1A3 UGT2B4 UGT2B17	2.81e-05	29	139	4	CID005375667
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A	KIF18A ZNF473 TBC1D30 CASP2 ZFX BBS10 VPS13D ATXN7	2.81e-05	196	139	8	1843_DN
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NEBL DTNA SPTBN1 CASP2 VPS13D KANK1 CCNE2 FGFR2	2.81e-05	196	139	8	5489_DN
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF473 DSPP SYNE1 RPS6KA2 APP PARD6B ATXN7 TBL1X	2.81e-05	196	139	8	6435_UP
Drug	Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A	TNIK NEBL DTNA NTRK2 CASP2 MAGI2 ARHGEF10 FURIN	2.92e-05	197	139	8	4555_UP
Drug	Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A	ABR TBC1D30 CASP2 APP PARD6B NBAS CCNE2 MPPE1	2.92e-05	197	139	8	5320_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ABR ZNF473 PCLO SPTBN1 ZNF236 NBAS PAPOLA MPPE1	2.92e-05	197	139	8	5500_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ABR NEBL KIAA0586 APP ZNF236 PARD6B EIF5 FGFR2	2.92e-05	197	139	8	7026_DN
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ZBTB48 DSPP CASP2 ZFX VPS13D ARHGEF10 FURIN FGFR2	3.02e-05	198	139	8	7473_UP
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	STAM2 DTNA KIAA0586 PARD6B DZANK1 VPS13D PAPOLA CCNE2	3.02e-05	198	139	8	3282_DN
Drug	Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A	STAM2 ABR TBC1D30 DTNA CASP2 PAPOLA SLF2 HCFC2	3.02e-05	198	139	8	2425_DN
Drug	Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A	KIF18A DTNA CASP2 APP ZNF236 TGFB1I1 PARD6B FURIN	3.02e-05	198	139	8	5391_DN
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	TNIK STAM2 ZNF473 RPS6KA2 ZFX VPS13D KANK1 BRCA2	3.02e-05	198	139	8	5742_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	ZNF473 TBC1D30 NEBL DSPP SYNE1 RPS6KA2 CASP2 ZFX	3.02e-05	198	139	8	6969_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ZNF473 ZBTB48 NEBL DSPP DTNA SLF2 FGFR2 TBL1X	3.02e-05	198	139	8	6001_DN
Drug	4-hydroxybiphenyl	STAM2 UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.03e-05	59	139	5	CID000007103
Drug	acetaminophen glucuronide	PDK4 UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.03e-05	59	139	5	CID000083944
Drug	Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ZBTB48 SPTBN1 ZBTB14 ZFX TGFB1I1 ZNF419 PARD6B DZANK1	3.13e-05	199	139	8	6822_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	DTNA NTRK2 SPTBN1 CASP2 ZFX PARD6B VPS13D PAPOLA	3.13e-05	199	139	8	3608_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A	NEBL PDK4 RPS6KA2 APP TGFB1I1 VPS13D HCFC2 MPPE1	3.13e-05	199	139	8	6492_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	TBC1D30 SPTBN1 THAP9 ZBTB14 ZNF419 ARHGEF10 FGFR2 MPPE1	3.13e-05	199	139	8	6929_UP
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; HL60; HT_HG-U133A	KIF18A STAM2 ZBTB48 CASP2 ZNF236 EPB41L3 ZFX CCNE2	3.25e-05	200	139	8	2954_DN
Drug	SB 203580; Up 200; 1uM; PC3; HT_HG-U133A	NEBL DTNA APP ZNF236 CREB5 ZBTB14 DZANK1 PBX1	3.25e-05	200	139	8	6894_UP
Drug	UDP-alpha-d-xylopyranose	APP UGT1A4 UGT1A3 UGT2B4 UGT2B17	3.29e-05	60	139	5	CID000001165
Drug	allyl phosphate	CSNK2A1 CSNK2A2	3.70e-05	2	139	2	CID000015390
Drug	afloqualone	UGT1A4 UGT1A3	3.70e-05	2	139	2	ctd:C033541
Drug	diethyl acetylenedicarboxylate	SYNE1 SPAG17	3.70e-05	2	139	2	CID000069803
Drug	NNAL	UGT1A4 UGT1A3 UGT2B4 UGT2B17	4.19e-05	32	139	4	CID000104856
Drug	R(-)-Denopamine	UGT1A4 UGT1A3 UGT2B4 UGT2B17	4.74e-05	33	139	4	CID000003818
Drug	AC1Q6OQG	UGT1A4 UGT1A3 UGT2B4 UGT2B17	4.74e-05	33	139	4	CID000009686
Drug	BP-3,6-quinol	UGT1A4 UGT1A3 UGT2B4 UGT2B17	4.74e-05	33	139	4	CID000119292
Drug	AC1NOWCJ	UGT1A4 UGT1A3 UGT2B4 UGT2B17	6.01e-05	35	139	4	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT1A4 UGT1A3 UGT2B4 UGT2B17	6.01e-05	35	139	4	CID010436171
Drug	estrone-3-glucuronide	UGT1A4 UGT1A3 UGT2B4 UGT2B17	6.01e-05	35	139	4	CID000115255
Drug	anisole	SYNE1 APP UGT1A4 UGT1A3	6.73e-05	36	139	4	CID000007519
Drug	l-borneol	UGT1A4 UGT1A3 UGT2B4 UGT2B17	7.51e-05	37	139	4	CID000010049
Drug	propranolol glucuronide	UGT1A4 UGT1A3 UGT2B4	7.72e-05	14	139	3	CID000119515
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; HL60; HT_HG-U133A	TBC1D30 RPS6KA2 APP VPS13D ARHGEF10 CCNE2 CSNK2A1	8.85e-05	171	139	7	2429_DN
Drug	Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A	ZNF473 TBC1D30 RPS6KA2 KANK1 ARHGEF10 CCNE2 TBL1X	8.85e-05	171	139	7	2723_DN
Drug	vanillin	TGFB1I1 UGT1A3 FGFR2 MAP2K2	9.27e-05	39	139	4	ctd:C100058
Drug	LY178550	DSPP APP CSNK2A2 TBL1X	9.27e-05	39	139	4	CID000444980
Drug	harmol	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.03e-04	40	139	4	CID000068094
Drug	1-ethyl-4-carbamoyl-5-methylcarbamoylimidazole	CSNK2A1 CSNK2A2	1.11e-04	3	139	2	CID000130883
Drug	testosterone glucuronide	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.13e-04	41	139	4	CID000108192
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KIF18A STAM2 NEBL KIAA0586 VPS13D HELZ HCFC2	1.22e-04	180	139	7	2859_DN
Drug	PTBP	STAM2 UGT1A4 UGT1A3 UGT2B4	1.24e-04	42	139	4	CID000007393
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZNF142 TRRAP ZBTB14 ZFX DNAJC2 TGFB1I1 EIF5	1.35e-04	183	139	7	7136_DN
Drug	Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; HL60; HT_HG-U133A	ZBTB48 DTNA STAM APP VPS13D EIF5 TBL1X	1.35e-04	183	139	7	1343_UP
Drug	androsterone glucuronide	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.36e-04	43	139	4	CID000114833
Drug	7,8-benzoquinoline	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.36e-04	43	139	4	CID000009191
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A4 UGT1A3 UGT2B4	1.42e-04	17	139	3	CID000003573
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; MCF7; HT_HG-U133A	CASP2 ZBTB14 KANK1 SLF2 CCNE2 CSNK2A1 PBX1	1.44e-04	185	139	7	5364_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	ZBTB48 NEBL RPS6KA2 SPTBN1 SYBU ZFX FGFR2	1.49e-04	186	139	7	6996_UP
Drug	MS-222	UGT1A4 UGT1A3 UGT2B4 UGT2B17	1.49e-04	44	139	4	CID000011400
Drug	0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A	NEBL SYNE1 DSN1 ZBTB14 TEX30 ZNF592 CCNE2	1.65e-04	189	139	7	7392_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZBTB48 NEBL ZBTB14 PARD6B DZANK1 ARHGEF10 SLF2	1.65e-04	189	139	7	5203_DN
Drug	Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	TBC1D30 SPTBN1 CASP2 SYBU ZNF419 PARD6B VPS13D	1.70e-04	190	139	7	2869_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	STAM2 ZNF473 CASP2 PARD6B PAPOLA FGFR2 MPPE1	1.76e-04	191	139	7	7195_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	PCLO KIAA0586 CASP2 APP DSN1 MOXD1 CSNK2A2	1.76e-04	191	139	7	1225_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A	STAM2 SYNE1 APP ZBTB14 ZFX ARHGEF10 PBX1	1.76e-04	191	139	7	6746_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	SOX2 ZBTB48 RPS6KA2 CASP2 ZNF419 PARD6B MAGI2	1.76e-04	191	139	7	2824_UP
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	TBC1D30 DTNA SPTBN1 TRPS1 KANK1 FURIN EIF5	1.82e-04	192	139	7	6166_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A	ZNF473 TBC1D30 SPTBN1 PAPOLA BRCA2 CCNE2 FGFR2	1.82e-04	192	139	7	5959_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A	ZNF473 CASP2 APP PARD6B PAPOLA FGFR2 MPPE1	1.88e-04	193	139	7	3209_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ZBTB48 DTNA CASP2 ZBTB14 BBS10 CCNE2 CSNK2A1	1.88e-04	193	139	7	3943_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; HL60; HT_HG-U133A	KIF18A STAM2 DTNA CASP2 ZBTB14 PAPOLA CCNE2	1.94e-04	194	139	7	1294_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	ZNF473 RPS6KA2 SPTBN1 ZNF236 VPS13D PAPOLA MPPE1	1.94e-04	194	139	7	2106_DN
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HG-U133A	UBR2 STAM2 RPS6KA2 APP TAOK3 PAPOLA TBL1X	2.00e-04	195	139	7	1949_DN
Drug	Arecoline hydrobromide [300-08-3]; Down 200; 17uM; HL60; HT_HG-U133A	TBC1D30 DTNA CASP2 PAPOLA CCNE2 HCFC2 MPPE1	2.00e-04	195	139	7	1303_DN
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A	FBXO40 DSPP PDK4 SYNE1 NTRK2 ARHGEF10 PBX1	2.00e-04	195	139	7	2152_UP
Drug	Chloroprene	SOX2 TNIK NEBL DTNA PDK4 CARMIL1 SPTBN1 AGR2 TRPS1 ZNF521 SOSTDC1 TMTC1 NRXN1 PTPRK ATXN7 CCNE2 CSNK2A1 CSNK2A2 EIF5 EPB41	2.02e-04	1348	139	20	ctd:D002737
Drug	Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A	DTNA PCLO CASP2 APP TGFB1I1 PARD6B ARHGEF10	2.06e-04	196	139	7	3849_DN
Drug	5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA	STAM2 ZNF473 NEBL KIAA0586 SYBU APP DZANK1	2.06e-04	196	139	7	960_DN
Drug	Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A	ZNF473 KIAA0586 ZNF419 PAPOLA SLF2 FGFR2 HCFC2	2.06e-04	196	139	7	7477_DN
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A	TBC1D30 SPTBN1 APP ZNF419 EIF5 FGFR2 TBL1X	2.06e-04	196	139	7	2628_DN
Drug	doxycycline; Down 200; 14.4uM; MCF7; HT_HG-U133A_EA	NEBL SPTBN1 KIAA0586 CASP2 PARD6B FGFR2 TBL1X	2.06e-04	196	139	7	1113_DN
Drug	Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CASP2 APP BBS10 PARD6B ATXN7 CCNE2 EIF5	2.06e-04	196	139	7	2631_DN
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	FBXO40 ZBTB48 RPS6KA2 SOSTDC1 VPS13D ARHGEF10 LEF1	2.06e-04	196	139	7	6273_UP
Drug	Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A	TNIK STAM2 ZNF473 DTNA CASP2 ZNF236 HCFC2	2.06e-04	196	139	7	2963_DN
Drug	Lymecycline [992-21-2]; Down 200; 6.6uM; HL60; HT_HG-U133A	KIF18A ZBTB48 TBC1D30 DTNA CASP2 ZNF236 ZFX	2.06e-04	196	139	7	2953_DN
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	DTNA CASP2 ZBTB14 ZFX ZNF419 PAPOLA FURIN	2.06e-04	196	139	7	4143_DN
Disease	Bipolar Disorder	SYNE1 NTRK2 RPS6KA2 PCLO APP MAGI2 NRXN1 BRCA2 ARHGEF10 ZNF592 FGFR2 MPPE1	1.68e-06	477	132	12	C0005586
Disease	severe acute respiratory syndrome, COVID-19	NTRK2 RPS6KA2 CREB5 MAGI2 NRXN1 INAVA CDK11B PBX1 CADPS2 TBL1X	3.47e-05	447	132	10	EFO_0000694, MONDO_0100096
Disease	central nervous system disease (implicated_via_orthology)	SEC31A SEC31B TAOK3	4.70e-05	16	132	3	DOID:331 (implicated_via_orthology)
Disease	Carcinoma of lung	NTRK2 BRCA2 CSNK2A3	1.45e-04	23	132	3	C0684249
Disease	epiandrosterone sulfate measurement	ZNF655 UGT2B17 MAP2K2	1.87e-04	25	132	3	EFO_0021120
Disease	Cleft palate, cleft lip, alcohol exposure measurement, parental genotype effect measurement	ANO2 ARHGEF10	1.97e-04	5	132	2	EFO_0003959, EFO_0005939, EFO_0009113, HP_0000175
Disease	GlcNAc sulfate conjugate of C21H34O2 steroid measurement	UGT3A1 PCDHB11	2.94e-04	6	132	2	EFO_0800663
Disease	androsterone sulfate measurement	ZNF655 UGT2B17 MAP2K2	4.33e-04	33	132	3	EFO_0021117
Disease	X-11793--oxidized bilirubin measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0021260
Disease	Succinimide measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0022118
Disease	X-11530 measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0800696
Disease	X-10458 measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0800692
Disease	X-24849 measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0800909
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0802740
Disease	X-16946 measurement	UGT1A4 UGT1A3	5.46e-04	8	132	2	EFO_0800766
Disease	response to anticonvulsant	TDRD15 NEBL ZNF521 MAGI2	5.85e-04	85	132	4	GO_0036277
Disease	physical activity	ANO2 ZNF521 MAGI2 PLEKHG1	6.67e-04	88	132	4	EFO_0003940
Disease	unipolar depression, bipolar disorder	SYNE1 NTRK2 PCLO TUBGCP6 ASXL3	6.98e-04	156	132	5	EFO_0003761, MONDO_0004985
Disease	X-11442 measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0021236
Disease	X-11441 measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0801036
Disease	X-11880 measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0802127
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A4 UGT1A3	7.00e-04	9	132	2	EFO_0004570, GO_0009410
Disease	Uterine leiomyoma	SYNE1 ZNF208 KANK1 ZNF257	7.57e-04	91	132	4	HP_0000131
Disease	bilirubin measurement, response to tenofovir	UGT1A4 UGT1A3	8.73e-04	10	132	2	EFO_0004570, EFO_0009279
Disease	X-21448 measurement	UGT1A4 UGT1A3	8.73e-04	10	132	2	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A4 UGT1A3	8.73e-04	10	132	2	EFO_0802185
Disease	X-23974 measurement	UGT1A4 UGT1A3	8.73e-04	10	132	2	EFO_0800867
Disease	melanoma	UBR4 TRRAP BRCA2 PTPRK MAP2K2 EPB41	8.99e-04	248	132	6	C0025202
Disease	metabolite measurement	UGT3A1 UGT1A4 TUBGCP6 UGT1A3 MAGI2 NBAS UGT2B4 UGT2B17 TBX20	9.65e-04	560	132	9	EFO_0004725
Disease	Mental Depression	NTRK2 PCLO APP NRXN1 ARHGEF10 FGFR2	1.02e-03	254	132	6	C0011570
Disease	histidine betaine (hercynine) measurement	UGT1A4 UGT1A3	1.06e-03	11	132	2	EFO_0800972
Disease	X-21796 measurement	UGT1A4 UGT1A3	1.06e-03	11	132	2	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A4 UGT1A3	1.06e-03	11	132	2	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A4 UGT1A3	1.06e-03	11	132	2	EFO_0010219
Disease	3-hydroxypropylmercapturic acid measurement	TNIK NTRK2 ZNF519 MAGI2 CSNK2A1 CSNK2A2 CADPS2	1.07e-03	352	132	7	EFO_0007014
Disease	Autistic Disorder	FBXO40 NTRK2 TRRAP NRXN1 GZMB CADPS2	1.17e-03	261	132	6	C0004352
Disease	p-cresol glucuronide measurement	UGT1A4 UGT1A3	1.27e-03	12	132	2	EFO_0800079
Disease	biliverdin measurement	UGT1A4 UGT1A3	1.27e-03	12	132	2	EFO_0021033
Disease	Alzheimer's disease biomarker measurement	NEBL RPS6KA2 ARHGEF10	1.31e-03	48	132	3	EFO_0006514
Disease	fructose measurement	TNIK UBR4	1.50e-03	13	132	2	EFO_0010477
Disease	retinol dehydrogenase 16 measurement	UGT1A4 UGT1A3	1.50e-03	13	132	2	EFO_0802007
Disease	X-19141 measurement	UGT2B4 UGT2B17	1.50e-03	13	132	2	EFO_0800799
Disease	polycystic kidney disease (implicated_via_orthology)	STAM2 STAM	1.74e-03	14	132	2	DOID:0080322 (implicated_via_orthology)
Disease	plasminogen activator inhibitor 1 measurement	RPS6KA2 PARP8 UBR4	1.84e-03	54	132	3	EFO_0004792
Disease	Depressive disorder	NTRK2 PCLO APP NRXN1 ARHGEF10 FGFR2	1.96e-03	289	132	6	C0011581
Disease	keratinocyte carcinoma	TRPS1 PARD6B KANK1 BRCA2	1.98e-03	118	132	4	EFO_0010176
Disease	chronic lymphocytic leukemia	KIF18A APP MAP2K2 LEF1	2.04e-03	119	132	4	EFO_0000095
Disease	ankle brachial index	SYBU NBAS	2.29e-03	16	132	2	EFO_0003912
Disease	pursuit maintenance gain measurement	CARMIL1 MAGI2 CSNK2A1 CSNK2A2	2.30e-03	123	132	4	EFO_0008433
Disease	Squamous cell carcinoma	SOX2 DSPP CSNK2A1 CSNK2A2	2.37e-03	124	132	4	C0007137
Disease	Multiple congenital anomalies	NRXN1 FGFR2	2.58e-03	17	132	2	C0000772
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A4 UGT1A3	2.58e-03	17	132	2	EFO_0004611, EFO_0007800
Disease	Cardiomyopathies	NEBL DTNA APP MAP2K2	2.81e-03	130	132	4	C0878544
Disease	angiopoietin-related protein 1 measurement	UGT1A4 UGT1A3	2.90e-03	18	132	2	EFO_0801382
Disease	progression free survival, ovarian carcinoma	NTRK2 NBAS	2.90e-03	18	132	2	EFO_0001075, EFO_0004920
Disease	unipolar depression	PCLO TRPS1 LYSMD4 CREB5 TUBGCP6 MAGI2 NBAS TMTC1 TAOK3 NRXN1 ARHGEF10 ASXL3 FURIN	2.99e-03	1206	132	13	EFO_0003761
Disease	squamous cell carcinoma (is_marker_for)	SOX2 FGFR2	3.23e-03	19	132	2	DOID:1749 (is_marker_for)
Disease	waist circumference	NEBL RPS6KA2 MRPL30 MOXD1 NRXN1 PTPRK CADPS2	3.25e-03	429	132	7	EFO_0004342
Disease	androsterone glucuronide measurement	UGT2B4 UGT2B17	3.58e-03	20	132	2	EFO_0800317
Disease	bipolar I disorder	TDRD15 SYNE1 RPS6KA2 ZNF592	3.76e-03	141	132	4	EFO_0009963
Disease	left atrial function	DSPP SEPHS1	3.94e-03	21	132	2	EFO_0004294
Disease	advanced glycosylation end product-specific receptor ligand measurement	DSPP PBX2	3.94e-03	21	132	2	EFO_0010762
Disease	tissue factor measurement	UGT1A4 UGT1A3	3.94e-03	21	132	2	EFO_0010623
Disease	Manic Disorder	NTRK2 RPS6KA2 ZNF592	4.01e-03	71	132	3	C0024713
Disease	neuroticism measurement, cognitive function measurement	NUP210L PCLO TRPS1 SYBU PTPRK ASXL3 ZNF655 FURIN	4.04e-03	566	132	8	EFO_0007660, EFO_0008354
Disease	cortical thickness	TNIK ANO2 EXD1 NUP210L RPS6KA2 SPTBN1 TRPS1 PCDHB11 SYBU PLEKHG1 VPS13D FURIN	4.31e-03	1113	132	12	EFO_0004840
Disease	X-24947 measurement	UGT2B4 UGT2B17	4.33e-03	22	132	2	EFO_0800910

Protein segments in the cluster

Peptide	Gene	Start	Entry
HQAVVLTPEVNMHIK	UGT1A3	56	P35503
RVAEKEPINKMSLHN	ABR	781	Q12979
KTSNKPLMIIHHLDE	AGR2	66	O95994
QEDPNAVLGRHKMHV	BOP1	286	Q14137
QKPIRKHRNMHCKVS	EPB41	201	P11171
KHLQDINIATPVHNM	ARHGEF10	1141	O15013
DKENHIKTLTGHLPM	CTAGE4	261	Q8IX94
DKENHIKTLTGHLPM	CTAGE6	261	Q86UF2
DKENHIKTLTGHLPM	CTAGE8	261	P0CG41
DKENHIKTLTGHLPM	CTAGE9	261	A4FU28
DKENHIKTLTGHLPM	CTAGE15	261	A4D2H0
VPKAVMHFLVNHVKD	DNM1L	666	O00429
HFEHVRMVDPKKAAQ	APP	511	P05067
APLGKHSHTLQEVKM	GZMB	151	P10144
FKKIPMEDRHNIQTH	CCNE2	346	O96020
SKPLERHVEKSMNLH	DSPP	21	Q9NZW4
AEHKQLEKLSLPHNM	BEST1	166	O76090
MAQKKRNPEISHRHQ	CCDC144CP	611	Q8IYA2
KPPQQMSRKEKAHHR	CDK11B	86	P21127
HLQPRVPEHSNNKMK	ANO2	236	Q9NQ90
IDMVITVKRHPQKVH	BBS10	701	Q8TAM1
QIKAAHKAMVLKHHP	DNAJC2	106	Q99543
KHSMQNRIVHSPEVK	ASXL3	1881	Q9C0F0
EKHQIMHRDVKPSNI	MAP2K2	186	P36507
ERMLEKHHKPGQQHL	PGBD4	491	Q96DM1
RPDNHRKKPHIVISM	PARD6B	121	Q9BYG5
DSDLMHVKPQHEQRK	LEF1	276	Q9UJU2
IKVRNRHHNVVPTMA	PDK4	121	Q16654
MRTTPKQEAAAKQHI	C8orf48	181	Q96LL4
EAKMRLKAALTHHPA	CREB5	231	Q02930
KMEKRLHAVPAANTV	FGFR2	161	P21802
AQARKHALNCHRMKP	PBX1	61	P40424
HIVKLPVNRQLKFMH	PARP8	651	Q8N3A8
AQAKKHALNCHRMKP	PBX2	71	P40425
NSHVVDMLRKNEGPH	HCFC2	476	Q9Y5Z7
LEAKRKLQQHNMPHT	MAGI2	381	Q86UL8
RNHGILMETHKELKP	LYSMD4	121	Q5XG99
VHKTKEMAANNPHLP	GPR179	691	Q6PRD1
EKHLQENKPTMEHKR	KIF18A	861	Q8NI77
DQRITQKEHFMTPKH	EXD1	421	Q8NHP7
KMFRHPSHVQLKVVA	MPPE1	141	Q53F39
MHRKQELDSSHPPKQ	PCLO	81	Q9Y6V0
QLPKHNLHVTKTLME	KANK1	146	Q14678
KPHITAAEGKLHNMI	IMMT	321	Q16891
LMPHSEKRHQQIKNF	KNTC1	2081	P50748
HIQEMLKAVSEAHQP	TUBGCP6	801	Q96RT7
HQKDAKHPQMIKVDF	NRXN1	526	Q9ULB1
HSTFQMPQKEDILKH	HELZ	751	P42694
TLKTDPEAFHQHMVK	NBAS	1731	A2RRP1
VAKVPAVNNVHMKHT	ATXN7	856	O15265
MDHLQKQPNTLRHVV	PASD1	406	Q8IV76
SHFHIKMRVIPDNRK	PCDHB11	176	Q9Y5F2
MHVKRKQLHQLLPNH	PAPOLA	486	P51003
DVKPHNVMIDHEHRK	CSNK2A3	156	Q8NEV1
VVAMHQAQLISKIPH	EIF5	321	P55010
AENKLMHILHANDPK	BRCA2	3176	P51587
RDMQHLVVQTSKPAH	FURIN	391	P09958
MKETNRRKSLHPIHQ	DSN1	101	Q9H410
KSAELHRMVVPKNSQ	CADPS2	456	Q86UW7
HRMVVPKNSQDSDLK	CADPS2	461	Q86UW7
KPPQQMSRKEKVHHR	CDK11A	86	Q9UQ88
PAHRIKQQSEHTLMD	CFAP100	586	Q494V2
RDVKPHNVMIDHQQK	CSNK2A2	156	P19784
DVKPHNVMIDHEHRK	CSNK2A1	156	P68400
MSRHKLAKHLQVCPA	FBXO40	76	Q9UH90
QLNKRMPTTHQIHVE	DTNA	91	Q9Y4J8
PNVMKKAHIRQDLIH	CARMIL1	791	Q5VZK9
MRQIQKEAKHLGPHR	FAM186A	946	A6NE01
NRPVITVAVMNKHHE	DZANK1	641	Q9NVP4
PMKELTHAVHKQQRA	INAVA	111	Q3KP66
GMHPHHQETLKKNRV	CASP2	31	P42575
KEQHPDMSVTKVVVH	EPB41L3	1061	Q9Y2J2
QLPVEHNFAMVVHTK	NUP210L	1236	Q5VU65
HAVKTLRNSKPNMVE	PTPRK	1406	Q15262
EEPLLKNMDHHRSKQ	RNF207	606	Q6ZRF8
QENPKMHNSEISKRL	SOX2	61	P48431
IKMLGLEKAHTPQVH	MRPL30	86	Q8TCC3
KLHQLQMDKLPSRHA	SYNE1	6901	Q8NF91
SERKIDQLMHPKNIH	TDRD15	1191	B5MCY1
PDLSKHNNHMAKVLT	CKM	21	P06732
QGKHNKLESAIHSPM	RESF1	856	Q9HCM1
MGRHKPHLALKQVEQ	NEPRO	76	Q6NW34
HNLPVLAKMAAVSKA	SEPHS1	291	P49903
ELHRKHVMELRQQPK	TAOK3	696	Q9H2K8
NEPIIKVSDHSNRMH	SEC31B	201	Q9NQW1
QDRHMLDSPQKSNIK	SLF2	61	Q8IX21
QENPKMHNSEISKRL	SOX1	71	O00570
MLKKHTNIIAQAVPH	RANBP6	301	O60518
KDNHNFMIHLNDPKE	SPAG17	1066	Q6Q759
MHSGHPSEKEIKAQQ	SPTBN1	916	Q01082
IKQTVPIHAANLHIM	CFAP20DC	206	Q6ZVT6
PADKAEHMKRQRHPR	AUP1	261	Q9Y679
QREPHMRKNIKGIHT	NTRK2	791	Q16620
RAHSVNNHAKPMEID	TBL1X	201	O60907
MERHTSHPNRKVPAK	TSACC	1	Q96A04
LQMHIKAKHRNERPH	ZBTB48	451	P10074
LDIHKRMQPLHIQIK	TRPS1	1026	Q9UHF7
RHENNMHSERKQVTP	ZBTB14	406	O43829
KLTLHKVIHMERNPA	ZNF99	831	A8MXY4
KVIHMERNPANVKNV	ZNF99	836	A8MXY4
EVLKKMHNAFAHLPQ	UGT3A1	311	Q6NUS8
VKNHSQRPATEQLMK	TNIK	271	Q9UKE5
AMKVAQDHVEPRKNS	TTLL8	506	A6PVC2
VSIQMPTIIRHQKNH	ZNF260	116	Q3ZCT1
VTQHQRMHTGEKPFK	ZNF519	391	Q8TB69
QAIKLSPSHHVAMVN	TMTC1	641	Q8IUR5
QMFKIPVFQEKHHVI	MOXD1	206	Q6UVY6
VAQNPLKHHSERTDM	THAP9	851	Q9H5L6
NAMKLSRIHHDQPVK	UGT2B4	441	P06133
NVHEEKMKNKHLITP	SAGE2P	391	A6NJ88
IHNSKEKIAKMEHGP	SRFBP1	181	Q8NEF9
MGPLRESKKEHRVQH	SYBU	1	Q9NX95
LQIHLKTMHLDKPEQ	ZNF521	421	Q96K83
FVQKPELMQHVKSTH	ZNF592	901	Q92610
ELMQHVKSTHGVPRN	ZNF592	906	Q92610
MRRVNHKDPHVAMQA	STAM	51	Q92783
MKRVNHKVPHVALQA	STAM2	51	O75886
LEKVAQKMQAPHKIH	TEX30	171	Q5JUR7
HIRVHKKNMPRTKSH	TBC1D30	731	Q9Y2I9
QNPDRESALKKTHMI	ZNF705EP	76	A8MWA4
QNPNRESALKKTHMI	ZNF705G	76	A8MUZ8
SMSPAKPVQHHRERK	SOSTDC1	181	Q6X4U4
LIRHQMSHTGEKPFK	ZNF621	166	Q6ZSS3
VHLTQHQKIHKEMPC	ZNF655	316	Q8N720
SNLMEHKRIHTGEKP	ZNF208	706	O43345
RRPSEKNQHIMRHHK	ZFX	786	P17010
ICPEIKKVDNHLQMH	ZNF613	76	Q6PF04
IHQMPDLTLHKKVSA	ZNF57	121	Q68EA5
CKKHMKRHQTVPSAV	ZNF236	1066	Q9UL36
NQPIRHKMVTALGTH	TGFB1I1	291	O43294
LNSMHKYQPRVHIIK	TBX20	221	Q9UMR3
HLAEAQVKMHRPKEA	TTC37	311	Q6PGP7
KAKQAILEMDAIHHP	PLEKHG1	426	Q9ULL1
LEQPPASQHQKSMHK	PLEKHG1	1001	Q9ULL1
MQQHRRLKHEGVKPH	ZNF142	1186	P52746
NEPIIKVSDHSNRMH	SEC31A	201	O94979
KPLKVQVMHSSIVAH	UBR2	296	Q8IWV8
PAKAKIQDMVAIRHT	UBR4	2206	Q5T4S7
TLMQHRKVHIGEKPF	ZNF419	441	Q96HQ0
AENEQMLKPHLHKIV	TRRAP	726	Q9Y4A5
KPILAQHQRIHTGEM	ZNF772	306	Q68DY9
ENIMKLSRIHHDQPV	UGT2B17	441	O75795
PSEGQVIRMSHKKFH	KIAA0586	1276	Q9BVV6
RLVQHQKMHTVKTPY	ZNF473	501	Q8WTR7
HQAVVLTPEVNMHIK	UGT1A4	56	P22310
HQKPMVHVKSEVLAV	VPS13D	4341	Q5THJ4
LTRHKMIHTGEKPFQ	ZNF257	331	Q9Y2Q1
KDVVSKMLHVDPHQR	RPS6KA2	646	Q15349
PEVKHAMEVNKHQSN	NEBL	146	O76041
DTPAMRHVKEAQNHI	NEBL	766	O76041